OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report
Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, et al.
Hematological Oncology (2021) Vol. 39, Iss. 4, pp. 570-574
Open Access | Times Cited: 14
Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, et al.
Hematological Oncology (2021) Vol. 39, Iss. 4, pp. 570-574
Open Access | Times Cited: 14
Showing 14 citing articles:
Response to anti‐SARS‐CoV ‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
Joanna Zaleska, Paulina Kwaśnik, Magdalena Paziewska, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 4, pp. 705-712
Open Access | Times Cited: 20
Joanna Zaleska, Paulina Kwaśnik, Magdalena Paziewska, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 4, pp. 705-712
Open Access | Times Cited: 20
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic
Abril Arellano-Llamas, Jorge Vela‐Ojeda, Alvaro Hernandez‐Caballero
Current Oncology Reports (2022) Vol. 24, Iss. 2, pp. 209-213
Open Access | Times Cited: 18
Abril Arellano-Llamas, Jorge Vela‐Ojeda, Alvaro Hernandez‐Caballero
Current Oncology Reports (2022) Vol. 24, Iss. 2, pp. 209-213
Open Access | Times Cited: 18
Cellular and humoral response to the fourth BNT162b2 mRNA COVID‐19 vaccine dose in patients with CLL
Ohad Benjamini, Rotem Gershon, Erez Bar‐Haim, et al.
European Journal Of Haematology (2022) Vol. 110, Iss. 1, pp. 99-108
Open Access | Times Cited: 15
Ohad Benjamini, Rotem Gershon, Erez Bar‐Haim, et al.
European Journal Of Haematology (2022) Vol. 110, Iss. 1, pp. 99-108
Open Access | Times Cited: 15
COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 545-545
Open Access | Times Cited: 8
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 545-545
Open Access | Times Cited: 8
SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort
Michele Merli, Isacco Ferrarini, Francesco Merli, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 128-138
Open Access | Times Cited: 12
Michele Merli, Isacco Ferrarini, Francesco Merli, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 128-138
Open Access | Times Cited: 12
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report
Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, et al.
Haematologica (2022) Vol. 107, Iss. 8, pp. 1955-1959
Open Access | Times Cited: 7
Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, et al.
Haematologica (2022) Vol. 107, Iss. 8, pp. 1955-1959
Open Access | Times Cited: 7
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors
Francesca Romana Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104408-104408
Closed Access | Times Cited: 1
Francesca Romana Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104408-104408
Closed Access | Times Cited: 1
Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
Current perspectives regarding SARS‐CoV‐2 vaccination in chronic lymphocytic leukemia
Stefano Molica, Constantine S. Tam, Aaron Polliack
Hematological Oncology (2022) Vol. 40, Iss. 3, pp. 313-319
Open Access | Times Cited: 4
Stefano Molica, Constantine S. Tam, Aaron Polliack
Hematological Oncology (2022) Vol. 40, Iss. 3, pp. 313-319
Open Access | Times Cited: 4
Immune correlates of protection by vaccine against SARS‐CoV ‐2 in patients with chronic lymphocytic leukaemia
Daniele Sorcini, Filomena De Falco, Marco Gargaro, et al.
British Journal of Haematology (2022) Vol. 201, Iss. 1, pp. 45-57
Open Access | Times Cited: 3
Daniele Sorcini, Filomena De Falco, Marco Gargaro, et al.
British Journal of Haematology (2022) Vol. 201, Iss. 1, pp. 45-57
Open Access | Times Cited: 3
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany
Claudia Baratè, Alessandro Sanna, E. Benedetti, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4251-4264
Closed Access | Times Cited: 1
Claudia Baratè, Alessandro Sanna, E. Benedetti, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4251-4264
Closed Access | Times Cited: 1
Management of infections for patient treated with ibrutinib in clinical practice
Claudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Claudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Reut Harel, Gilad Itchaki
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 60-72
Open Access
Reut Harel, Gilad Itchaki
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 60-72
Open Access
